Possibly Misleading Pharmaceutical Advertising On TV: A 2023 Ad for Ingrezza.

J Clin Psychopharmacol

From Tufts University School of Medicine, Center for the Study of Drug Development, Boston, Massachusetts.

Published: April 2024

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0000000000001861DOI Listing

Publication Analysis

Top Keywords

misleading pharmaceutical
4
pharmaceutical advertising
4
advertising 2023
4
2023 ingrezza
4
misleading
1
advertising
1
0
1
ingrezza
1

Similar Publications

Gene expression biomarkers have the potential to identify genotoxic and non-genotoxic carcinogens, providing opportunities for integrated testing and reducing animal use. In August 2022, an International Workshops on Genotoxicity Testing (IWGT) workshop was held to critically review current methods to identify genotoxicants using transcriptomic profiling. Here, we summarize the findings of the workgroup on the state of the science regarding the use of transcriptomic biomarkers to identify genotoxic chemicals in vitro and in vivo.

View Article and Find Full Text PDF

The National Institute for Health and Care Excellence (NICE) was established a quarter of a century ago in 1999 to regulate the cost-effectiveness of pharmaceuticals (and other health technologies) for the NHS. Drawing on medical sociology theories of corporate bias, neoliberalism, pluralism/polycentricity and regulatory capture, the purpose of this article is to examine the applicability of those theories to NICE as a key regulatory agency in the UK health system. Based on approximately 7 years of documentary research, interviews with expert informants and observations of NICE-related meetings, this paper focuses particularly on NICE's relationship with the interests of the pharmaceutical industry compared with other stakeholder interests at the meso-organisational level.

View Article and Find Full Text PDF

Objective: During the severe acute respiratory syndrome coronavirus 2 pandemic, could be observed an established use of online information in the field of coronavirus disease worldwide. As a systematic review study, the present investigation aimed to evaluate related studies about digital health/e-health literacy among university students in the coronavirus disease 2019 era.

Methods: Three electronic bibliographic databases (PubMed/Medline, Scopus, and Google Scholar) were searched from 2020 until June 2022, and articles were screened according to pre-established inclusion criteria.

View Article and Find Full Text PDF

Nutraceuticals: a promising, yet unregulated Frontier in Healthcare.

Eur J Clin Nutr

December 2024

Faculty of Data Science, Musashino University, Tokyo, Japan.

Nutraceuticals, with their potential health benefits, are increasingly being used to manage a variety of health conditions. The global market for nutraceuticals, valued at USD 540 billion in 2022, is projected to reach USD 1025 billion by 2030. This paper delves into the beneficial impacts of emerging nutraceuticals on a spectrum of medical disorders, drawing from credible sources from the National Library of Medicine.

View Article and Find Full Text PDF

CISepsis: a causal inference framework for early sepsis detection.

Front Cell Infect Microbiol

December 2024

School of Electrical and Information Engineering, Tianjin University, Tianjin, China.

Introduction: The early prediction of sepsis based on machine learning or deep learning has achieved good results.Most of the methods use structured data stored in electronic medical records, but the pathological characteristics of sepsis involve complex interactions between multiple physiological systems and signaling pathways, resulting in mixed structured data. Some researchers will introduce unstructured data when also introduce confounders.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!